• Conducting Science Marketing Development Audits (SMDA) to help development teams align scientific
    hypotheses and date with marketing messages and needs.

  • Conducting in-depth Key Opinion Leader (KOL) interviews & Scientific Advisory Board (SAB) meetings

  • Providing processes to define transparent objective go/no-go hurdles to enable informed decisions and
    establish objective criteria for continuing or ending a project.

We are a boutique agency that provides effective processes to support to biopharmaceutical executives
and product development teams engaged in new product planning.




    Supporting Biopharmaceutical Developments

  • Supporting needs for high-quality regulatory documentation, professional publications, and medical
    communications

  • Strengthening internal and external communication to influence decision makers and expedite approvals

  • Supporting clients' scientific and marketing messages to overcome issues from preclinical planning
    through NDA filing and marketing




Science

Knowledge

Communication
Title>De Young & Hayden, San Francisco Bay Area Biopharm consultants, SABs, Due Diligence, Medical Writing, Marketing



   De Young & Hayden                                                                               Link to DYH Blog

This website Copyright 2007 De Young & Hayden, LLC.
.

    "Larry and Brad worked with us on due diligence projects including product evaluation. They provided the kind of information we needed to
    support our internal decision making process.  Due to Larry’s & Brad’s scientific, biopharmaceutical and therapeutic area expertise, this team
    required minimum briefing and guidance which allowed us to meet challenging project deadlines. Furthermore, we were also impressed with
    the top-level Key Opinion Leaders that they were able to bring to our projects. In summary, premium service at very reasonable cost."
    Christian Pangratz, Director/Program Leader, NEKTAR THERAPEUTICS